Transaction #2976 · Form 4 · 0002021198-25-000006
MapLight Therapeutics, Inc. · Stock award · Voting Common Stock
MapLight Therapeutics, Inc. · Transacted October 27, 2025 · Filed October 28, 2025
What does this filing report?
An SEC Form 4 filing for MapLight Therapeutics, Inc. records a stock award involving Voting Common Stock on October 27, 2025. The reported quantity was 34,390. The filing date is October 28, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- MapLight Therapeutics, Inc.
- Company CIK
- 0001770069
- Security type
- Non-derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 34,390
- Reported price
- 0 · See footnotes
- Reference value
- 0
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 399,671
- Ownership description
- Not reported
- SEC acceptance time
- Oct 28, 2025, 4:15 PM EDT
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Malenka Robert C. ↗
Director
CIK 0002021198
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Filing footnotes & remarks
- F1
- Represents a restricted stock unit ("RSU") award. 25% of the RSUs shall vest on October 1, 2026, and 1/16th of the RSUs shall vest on each subsequent January 1, April 1, July 1 and October 1 thereafter, subject to the Reporting Person's continued service through each vesting date.
- F2
- Each RSU represents a contingent right to receive one share of voting common stock of the Issuer.
- F3
- The Series C Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1-for-16.8 basis, and had no expiration date.
- F4
- The shares are held by the Robert C. Malenka Living Trust U/A DTD 08/21/2012, of which the Reporting Person is the sole trustee and has voting and dispositive power.
- F5
- 1/4th of the total shares underlying the option shall vest on October 1, 2026, and 1/48th of the total shares shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continued service through each vesting date.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.